Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer

We found that FTY720 enhanced the efficacy of doxorubicin by suppression of drug-induced inflammation, and combination therapy showed stronger effect in obesity-related breast cancer.